本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

20.12
-0.0700-0.35%
盘后20.700.5800+2.88%19:33 EDT
成交量:125.78万
成交额:2,534.62万
市值:10.31亿
市盈率:-5.03
高:20.64
开:20.21
低:19.60
收:20.19
52周最高:21.31
52周最低:9.24
股本:5,122.25万
流通股本:2,791.69万
量比:0.91
换手率:4.51%
股息:- -
股息率:- -
每股收益(TTM):-3.9996
每股收益(LYR):-3.0497
净资产收益率:-190.18%
总资产收益率:-60.98%
市净率:-380.15
市盈率(LYR):-6.60

数据加载中...

2023/12/29

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/29

重要事件披露

Form 8-K - Current report
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/08

重要事件披露

Form 8-K - Current report
2023/09/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/07/10

重要事件披露

Form 8-K - Current report
2023/06/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/14

重要事件披露

Form 8-K - Current report
2023/03/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/09

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals